Greece’s Financial Crisis and Devastated Healthcare System - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Greece’s Financial Crisis and Devastated Healthcare System
Greece’s economic crisis has battered the country’s healthcare system, resulting in medicine shortages, market withdrawals and falling profits for the pharma industry.


Pharmaceutical Technology Europe


References

1. A. Kentikelenis, "Health effects of financial crisis: omens of a Greek tragedy" (Lancet website, 2011) http://ww.thelancet.com/, accessed 27 Feb., 2012.

2. A. Carassava, "Euro crisis: Why Greece is the sick man of Europe" (BBC News website, 2011). http://www.bbc.co.uk/, accessed 27 Feb., 2012.

3. Healthcare Economist, "Health Care Around the World: Greece" (Healthcare Economist website, 2008). http://healthcare-economist.com/, accessed 27 Feb., 2012.

4. E. Karamanoli, "Greece's financial crisis dries up drug supply" (Lancet website 2012). http://www.thelancet.com/, accessed 27 Feb., 2012.

5. N. Kresge, "Greek Crisis Dries Up Drug Supply as Even Aspirin Can't Be Found" (Bloomber GusinessWeek website, 2012). http://www.businessweek.com/, accessed 27 Feb., 2012.

6. Pharmaceutical-Technology, "Greece confirms state pharmaceutical spend" (Pharmaceutical-Technology website, 2012). http://www.pharmaceutical-technology.com/, accessed 27 Feb., 2012.

7. Pharmalot, "Novo Nordisk Pulls Insulin From Greece Over Money" (Pharmalot website, 2010). http://www.pharmalot.com/, accessed 27 Feb., 2012.

8. L. Taylor, "Danish drugmakers' "no" to Greek price cuts" (Pharma Times, 2010). http://www.pharmatimes.com/, accessed 27 Feb., 2012.

9. A. Roy, "America's Future? Greece Defaults on Cancer Treatments in State-Owned Hospitals" (Forbes, 2011). http://www.forbes.com/, accessed 27 Feb., 2012.

10. C. Papachlimintzos, "Medicine in Greece is cheap" (Athens News, 2011). http://www.athensnews.gr, accessed 27 Feb., 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology Europe,
Click here